| Novel Therapy for FLT3-ITD Acute Myeloid Leukemia Utilizing the Combination of CUDC-907 and Gilteritinib | |
| Knight, Tristan; Qiao, Xinan; Edwards, Holly; Lin, Hai; Taub, Jeffrey W.; Ge, Yubin | |
| 刊名 | BLOOD
 |
| 2018 | |
| 卷号 | 132 |
| ISSN号 | 0006-4971 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3536920 |
| 专题 | 吉林大学白求恩第一医院 |
| 推荐引用方式 GB/T 7714 | Knight, Tristan,Qiao, Xinan,Edwards, Holly,et al. Novel Therapy for FLT3-ITD Acute Myeloid Leukemia Utilizing the Combination of CUDC-907 and Gilteritinib[J]. BLOOD,2018,132. |
| APA | Knight, Tristan,Qiao, Xinan,Edwards, Holly,Lin, Hai,Taub, Jeffrey W.,&Ge, Yubin.(2018).Novel Therapy for FLT3-ITD Acute Myeloid Leukemia Utilizing the Combination of CUDC-907 and Gilteritinib.BLOOD,132. |
| MLA | Knight, Tristan,et al."Novel Therapy for FLT3-ITD Acute Myeloid Leukemia Utilizing the Combination of CUDC-907 and Gilteritinib".BLOOD 132(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论